Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

57.48%

54.92%

64.90%

Annual Dental Visits (ADV) Total

0.33%

0.39%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

38.91%

41.66%

46.74%

Appropriate Testing for Pharyngitis (CWP)

71.86%

76.73%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

87.16%

90.09%

93.08%

Asthma Medication Ratio (AMR) Total

70.95%

72.94%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

54.95%

64.06%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

44.77%

41.85%

68.61%

Breast Cancer Screening (BCS)

42.04%

41.23%

55.25%

Cervical Cancer Screening (CCS)

36.50%

41.85%

59.85%

Childhood Immunization Status (CIS) Combination #10

32.12%

23.11%

35.04%

Chlamydia Screening in Women (CHL) Total

54.06%

55.18%

61.07%

Controlling High Blood Pressure (CBP)

43.55%

36.01%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

77.94%

77.94%

80.86%

Eye Exam for Patients With Diabetes (EED)

31.87%

31.14%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

13.11%

22.26%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

39.72%

35.46%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

18.48%

22.21%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

53.78%

50.34%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

35.82%

54.84%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

25.79%

35.28%

55.72%

Immunizations for Adolescents (IMA) Combination #2

21.90%

21.41%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

16.73%

22.69%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

29.45%

32.13%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

29.07%

39.62%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

38.83%

42.81%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

76.78%

77.62%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

85.75%

83.43%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

75.37%

87.82%

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

62.53%

63.50%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

56.69%

60.10%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

17.75%

13.91%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

2.45%

6.90%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

79.48%

80.87%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

54.89%

80.71%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

63.75%

63.10%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

58.53%

75.92%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

71.60%

55.56%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

71.04%

65.86%

75.44%

Use of Opioids at High Dosage (HDO)

4.05%

7.29%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

1.21%

0.81%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

68.13%

52.07%

83.21%